Australasian Leukaemia and Lymphoma Group   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Canberra Australia (1973)

Organization Overview

First Clinical Trial
1999
NCT00004179
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now